234 related articles for article (PubMed ID: 21487387)
1. What can molecular pathology contribute to the management of renal cell carcinoma?
Stewart GD; O'Mahony FC; Powles T; Riddick AC; Harrison DJ; Faratian D
Nat Rev Urol; 2011 May; 8(5):255-65. PubMed ID: 21487387
[TBL] [Abstract][Full Text] [Related]
2. From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma.
Arsanious A; Bjarnason GA; Yousef GM
Mol Cancer; 2009 Mar; 8():20. PubMed ID: 19291329
[TBL] [Abstract][Full Text] [Related]
3. The Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma.
Hu SL; Chang A; Perazella MA; Okusa MD; Jaimes EA; Weiss RH;
J Am Soc Nephrol; 2016 Aug; 27(8):2227-37. PubMed ID: 26961346
[TBL] [Abstract][Full Text] [Related]
4. Renal cell carcinoma: new insights and challenges for a clinician scientist.
Shingarev R; Jaimes EA
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F145-F154. PubMed ID: 28381462
[TBL] [Abstract][Full Text] [Related]
5. Management of Renal Cell Carcinoma: Promising Biomarkers and the Challenges to Reach the Clinic.
Lyskjær I; Iisager L; Axelsen CT; Nielsen TK; Dyrskjøt L; Fristrup N
Clin Cancer Res; 2024 Feb; 30(4):663-672. PubMed ID: 37874628
[TBL] [Abstract][Full Text] [Related]
6. Artificial Intelligence in Pathomics and Genomics of Renal Cell Carcinoma.
Knudsen JE; Rich JM; Ma R
Urol Clin North Am; 2024 Feb; 51(1):47-62. PubMed ID: 37945102
[TBL] [Abstract][Full Text] [Related]
7. Molecular insight into renal cancer and latest therapeutic approaches to tackle it: an updated review.
Murali R; Gopalakrishnan AV
Med Oncol; 2023 Nov; 40(12):355. PubMed ID: 37955787
[TBL] [Abstract][Full Text] [Related]
8. Incremental value of radiomics with machine learning to the existing prognostic models for predicting outcome in renal cell carcinoma.
Xing J; Liu Y; Wang Z; Xu A; Su S; Shen S; Wang Z
Front Oncol; 2023; 13():1036734. PubMed ID: 37188171
[TBL] [Abstract][Full Text] [Related]
9. Visualization of epithelial cell adhesion molecule-expressing renal cell carcinoma xenografts using designed ankyrin repeat protein Ec1 labelled with
Tolmachev V; Bodenko V; Orlova A; Schulga A; Deyev SM; Vorobyeva A
Oncol Lett; 2023 Jan; 25(1):12. PubMed ID: 36478911
[TBL] [Abstract][Full Text] [Related]
10. Glycosylation in Renal Cell Carcinoma: Mechanisms and Clinical Implications.
Zhu X; Al-Danakh A; Zhang L; Sun X; Jian Y; Wu H; Feng D; Wang S; Yang D
Cells; 2022 Aug; 11(16):. PubMed ID: 36010674
[TBL] [Abstract][Full Text] [Related]
11. Exploring synthetic lethal network for the precision treatment of clear cell renal cell carcinoma.
Liu Z; Lin D; Zhou Y; Zhang L; Yang C; Guo B; Xia F; Li Y; Chen D; Wang C; Chen Z; Leng C; Xiao Z
Sci Rep; 2022 Aug; 12(1):13222. PubMed ID: 35918352
[TBL] [Abstract][Full Text] [Related]
12. Identification of a differentiation-related prognostic nomogram based on single-cell RNA sequencing in clear cell renal cell carcinoma.
Xia ZN; Wu JG; Yao WH; Meng YY; Jian WG; Wang TD; Xue W; Yu YP; Cai LC; Wang XY; Zhang P; Li ZY; Zhou H; Jiang ZC; Zhou JY; Zhang C
Sci Rep; 2022 Jun; 12(1):10973. PubMed ID: 35768519
[TBL] [Abstract][Full Text] [Related]
13. Evaluating Established Roles, Future Perspectives and Methodological Heterogeneity for Wilms' Tumor 1 (WT1) Antigen Detection in Adult Renal Cell Carcinoma, Using a Novel N-Terminus Targeted Antibody (Clone WT49).
Novacescu D; Cut TG; Cumpanas AA; Latcu SC; Bardan R; Ferician O; Secasan CC; Rusmir A; Raica M
Biomedicines; 2022 Apr; 10(4):. PubMed ID: 35453662
[TBL] [Abstract][Full Text] [Related]
14. Systemic Injection of Oncolytic Vaccinia Virus Suppresses Primary Tumor Growth and Lung Metastasis in Metastatic Renal Cell Carcinoma by Remodeling Tumor Microenvironment.
Park JS; Lee ME; Jang WS; Kim J; Park SM; Oh K; Lee N; Ham WS
Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052851
[TBL] [Abstract][Full Text] [Related]
15. RB1CC1 functions as a tumor-suppressing gene in renal cell carcinoma via suppression of PYK2 activity and disruption of TAZ-mediated PDL1 transcription activation.
Chen P; Duan Y; Lu X; Chen L; Zhang W; Wang H; Hu R; Liu S
Cancer Immunol Immunother; 2021 Nov; 70(11):3261-3275. PubMed ID: 33837850
[TBL] [Abstract][Full Text] [Related]
16. miR-30b-5p up-regulation related to the dismal prognosis for patients with renal cell cancer.
Zhang C; Pan X; Peng X; Liu K; Wang J; Zhao L; Chen X; Huang G; Li H; Ye J; Lai Y
J Clin Lab Anal; 2021 Feb; 35(2):e23599. PubMed ID: 33247622
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-203 inhibits epithelial-mesenchymal transition, migration, and invasion of renal cell carcinoma cells via the inactivation of the PI3K/AKT signaling pathway by inhibiting CAV1.
Han N; Li H; Wang H
Cell Adh Migr; 2020 Dec; 14(1):227-241. PubMed ID: 32990143
[TBL] [Abstract][Full Text] [Related]
18. The emerging role of the piRNA/piwi complex in cancer.
Liu Y; Dou M; Song X; Dong Y; Liu S; Liu H; Tao J; Li W; Yin X; Xu W
Mol Cancer; 2019 Aug; 18(1):123. PubMed ID: 31399034
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Profiling of Primary and Metastatic ccRCC Reveals a High Homology of the Metastases to a Subregion of the Primary Tumour.
Ferronika P; Hof J; Kats-Ugurlu G; Sijmons RH; Terpstra MM; de Lange K; Leliveld-Kors A; Westers H; Kok K
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31212796
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of ST6GalNAc-1 expression in patients with non-metastatic clear cell renal cell carcinoma.
Bai Q; Liu L; Xi W; Wang J; Xia Y; Qu Y; Xiong Y; Long Q; Xu J; Guo J
Oncotarget; 2018 Jan; 9(3):3112-3120. PubMed ID: 29423033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
